ResMed Inc. (RSMDF) Return on equity 2017–2026
ResMed Inc. (RSMDF) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
23.1%FY2026 · since FY2017: 17.5% → 23.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | 23.1% | -0.3 pp |
| FY2025 | 23.5% | +2.5 pp |
| FY2024 | 21.0% | -0.7 pp |
| FY2023 | 21.7% | -1.5 pp |
| FY2022 | 23.2% | +6.7 pp |
| FY2021 | 16.4% | -8.5 pp |
| FY2020 | 24.9% | +5.4 pp |
| FY2019 | 19.5% | +4.2 pp |
| FY2018 | 15.3% | -2.1 pp |
| FY2017 | 17.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More RSMDF financial trends
RSMDF RevenueRSMDF Net incomeRSMDF Net marginRSMDF Gross profitRSMDF Gross marginRSMDF Operating incomeRSMDF Operating marginRSMDF Operating cash flowRSMDF Free cash flowRSMDF Capital expendituresRSMDF Stock buybacksRSMDF Dividends paidRSMDF Total assetsRSMDF Total liabilitiesRSMDF Shareholders’ equityRSMDF overview →